20
Jun

Biotech upstart Kite Pharma made its Wall Street debut Friday, pulling off an upsized IPO on the strength of investor fervor over a novel, headline-making approach to treating cancer.

…read more

Source: Kite Pharma rides the CAR-T current to a $128M IPO

    

0 No comments